CD4-GZMA (Granzyme A) TIL cells showed an association with prognosis and may yield therapeutic benefits in HCC immunotherapy.34 Another study discovered a subset of activated CD8+ T cells that highly expressed XCL1 and correlated with a better survival rate. The gene discussed is CD8A; the disease is hepatocellular carcinoma.